Search results for: "johnson johnson"

(218 records)

You need to be a subscriber to read this article.
Click here to find out more.
Pharmaceutical
Zika outbreak gives rise to global fears

Zika outbreak gives rise to global fears

Zika may not be a new virus but its newly confirmed ability to cause foetal brain abnormalities makes the search for a treatment or a vaccine a high priority. Dr Sarah Houlton...

Johnson Matthey and Domainex link up to enhance discovery and development services

The firms will provide simplified target-to-lead identification, optimisation, safety/toxicology, pre-clinical and clinical API supply services

Schutz Dishman Biotech to become Dishman subsidiary

Dishman acquires further 50% stake from joint venture partner Schutz and Co.

India approves drug to treat multi-drug resistant TB

The anti-TB drug has been rolled out under the Revised National Tuberculosis Control Programme and is part of the co-ordinated programme between the government and Johnson &...
You need to be a subscriber to read this article.
Click here to find out more.
Media
Flying the flag for quality

Flying the flag for quality

CPhI Pharma Insights recently published its report on the US market – produced in collaboration with research partner GBR. It reveals that while the US leads the world in...

LabConnect builds new biorepository in Johnson City, Tennessee

Has the capacity to offer absolute protection for more than eight million samples

Difficult trading conditions in key markets dampen Johnson Matthey's sales in Q3

Sales in Fine Chemicals affected by sale of Research Chemicals division to Alfa Aesar
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing
A design of experiments approach to optimising APIs

A design of experiments approach to optimising APIs

Design of Experiments (DoE) is increasingly used to screen and optimise chemical processes. Steve Collier, Director of R&D and Manufacturing, JM Pharma Materials & Services,...

Consortium of UK Universities and global pharma companies launch £40m innovation fund

Apollo Therapeutics Fund will support translation of academic science into medicines for a broad range of diseases

Johnson Matthey expands R&D and scale-up facilities in Cambridge, UK

Expansion brings additional process research and development services and kilo-scale manufacture to the growing site
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients
Ingredients see a drive for more science

Ingredients see a drive for more science

The need for greater solubility and bioavailability of new medicines, as well as increasing manufacturing efficiencies are driving developments in ingredients. Susan Birks...

Rheumatoid arthritis – sarilumab

Not all patients respond well to or tolerate TNF-alpha inhibitors, and an alternative strategy might be to treat with a drug against the interleukin-6 receptor alpha

Enterome collaborates with J&J Innovation to develop novel targets and therapeutics for Crohn’s disease

French firm will receive an upfront payment plus R&D funding from Janssen

Cypralis links up with J&J Innovation in neurodegenerative diseases

Cypralis and Janssen Pharmaceuticals aim to develop new cyclophilin inhibitors for neurogenerative diseases

Janssen and Hanmi agree to develop a novel clinical-stage biologic to treat diabetes and obesity

Commercialisation of oxyntomodulin-based therapy will bolster Janssen's metabolism portfolio

Johnson & Johnson to purchase Novira Therapeutics

Will complement and strengthen J&J's existing pipeline to combat Hepatitis B

Trending Articles

  1. Loftware and RiseNow partner to strengthen supply chain traceability and compliance in healthcare settings The alliance pairs Loftware's SAP-integrated product identification platform with RiseNow's procurement and supply chain advisory services, delivering end-to-end track-and-trace capabilities for regulated industries where audit readiness and patient safety are critical
  2. AlzeCure receives $12m upfront as NeuroRestore Alzheimer's platform licensing deal with QuantumCell closes The payment — comprising $7m in licence fees and $5m direct investment — kicks off a collaboration worth more than $2.2bn in potential milestones, with QuantumCell assuming global rights to ACD856 and the NeuroRestore platform
  3. As new CTO, Christian Reichardt is driving the technological advancement of Optima Pharma This investment is driven by growth areas such as biologics, GLP-1 products, and other sterile pharmaceuticals, as well as the increasing demand for isolator and high-potency technologies
  4. Bespak awarded gold EcoVadis sustainability rating for its Holmes Chapel (UK) site Bespak, the specialist inhalation CDMO, has achieved a Gold EcoVadis sustainability rating for its Holmes Chapel site. The result places Bespak among the top 5% of companies assessed worldwide
  5. Irish manufacturer brings EU GMP-certified dronabinol API to UK specials market Dunbar Pharmaceuticals partners with IPS Pharma to supply plant-derived dronabinol API for UK Specials-pathway cannabis medicines, following its earlier expansion into Germany

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Manufacturing Labtex and Diehm
Partners in precise and sustainable glass reactor systems since 2005

Partners in precise and sustainable glass reactor systems since 2005

Read more
Sustainability Matt explains how the NSF QP Alumni community provides lasting professional connections, peer support and continuing development, helping Qualified Persons share challenges and...
Why QP Alumni connections continue to matter long after QP Training

Why QP Alumni connections continue to matter long after QP Training

Read more
Manufacturing High Point completes three regulatory inspections, enabling commercial API manufacturing for the US, Japan and Australia
Cambrex High Point completes FDA, PMDA and TGA pre-approval inspections, advancing commercial manufacturing capabilities

Cambrex High Point completes FDA, PMDA and TGA pre-approval inspections, advancing commercial manufacturing capabilities

Read more
Manufacturing Expansion adds commercial-scale batch tableting capacity and strengthens integrated ASD manufacturing
Hovione completes €40 million expansion of Loures tablet manufacturing center

Hovione completes €40 million expansion of Loures tablet manufacturing center

Read more
Manufacturing Pharmaceutical packaging, filling and digital technologies will be on display at the Milan exhibition
Marchesini Group showcases pharma and aseptic solutions at CPHI 2026

Marchesini Group showcases pharma and aseptic solutions at CPHI 2026

Read more
Manufacturing Combining expertise across the UK and US, Codis supports customers from material characterisation and formulation development through scale-up, clinical studies and through to...
Codis brings together formulation development, spray drying and commercial supply

Codis brings together formulation development, spray drying and commercial supply

Read more
Packaging The global market for weight management drugs is seeing dynamic growth and increases the demand for powerful self-injection systems
Schreiner MediPharm develops multifunctional label for SHL Medical’s Quanta Pen

Schreiner MediPharm develops multifunctional label for SHL Medical’s Quanta Pen

Read more
Analysis New brand identity and website mark the expansion of Tagomics’ product portfolio into organ health monitoring
Tagomics introduces a first-in-class cfDNA-based blood test for multi-organ drug safety monitoring

Tagomics introduces a first-in-class cfDNA-based blood test for multi-organ drug safety monitoring

Read more